Stay updated on HPN536 Clinical Trial Mesothelin Expression
Sign up to get notified when there's something new on the HPN536 Clinical Trial Mesothelin Expression page.

Latest updates to the HPN536 Clinical Trial Mesothelin Expression page
- Check2 days agoChange DetectedThe clinical-trial record for HPN536 is displayed, describing a completed Phase 1 study for patients with advanced mesothelin-expressing cancers, its eligibility criteria, treatment arms, study locations, and measured outcomes.SummaryDifference46%

- Check9 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA general NIH banner was added announcing updates to terminology during a federal transition, and the site revision changed from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe 403 Forbidden error page content was removed. This change eliminates the blocked access portion of the page.SummaryDifference0.5%

- Check51 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record. This indicates the page content is currently inaccessible and the normal study details and navigation are replaced by the error screen.SummaryDifference17%

Stay in the know with updates to HPN536 Clinical Trial Mesothelin Expression
Enter your email address, and we'll notify you when there's something new on the HPN536 Clinical Trial Mesothelin Expression page.